down arrow

908 Devices, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US65443P1021
USD
6.65
0.56 (9.2%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

6.016.65

52 Week

1.819.34
Valuation
Technical
Day's Volume

CASH

340.4 k

Shareholding (Mar 2025)

FII

4.45%

Held by 39 FIIs

DII

59.42%

Held by 37 DIIs

Promoter

2.32%

How big is 908 Devices, Inc.?

22-Jun-2025

As of Jun 18, 908 Devices, Inc. has a market capitalization of 263.58 million, with net sales of 61.42 million and a net profit of -71.14 million over the latest four quarters. Shareholder's funds are 114.59 million, and total assets are valued at 159.48 million as of Dec 24.

Market Cap: As of Jun 18, 908 Devices, Inc. has a market capitalization of 263.58 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 61.42 million, while the sum of Net Profit is -71.14 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the Shareholder's Funds amount to 114.59 million, and the Total Assets are valued at 159.48 million.

Read More

What does 908 Devices, Inc. do?

22-Jun-2025

908 Devices, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $12 million and a net loss of $10 million as of March 2025, with a market cap of $263.58 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -16.05%.

Overview: <BR>908 Devices, Inc. operates within the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 12 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -10 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 263.58 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.77 <BR>Return on Equity: -16.05% <BR>Price to Book: 1.65<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Should I buy, sell or hold 908 Devices, Inc.?

22-Jun-2025

Is 908 Devices, Inc. technically bullish or bearish?

20-Sep-2025

As of July 29, 2025, 908 Devices, Inc. shows a mildly bullish trend with strong year-to-date performance of 210%, despite some caution from weekly indicators.

As of 29 July 2025, the technical trend for 908 Devices, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a bullish daily moving average and bullish Bollinger Bands on both weekly and monthly time frames. However, the weekly MACD and KST are mildly bearish, indicating some caution. The stock has performed significantly well year-to-date with a return of 210.0%, compared to the S&P 500's 12.22%, and has also outperformed the index over the past year with an 84.82% return versus 17.14%. Overall, while there are mixed signals, the strength of the bullish indicators suggests a positive outlook.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared positive results in Mar'2025 after 2 consecutive negative quarters

  • PRE-TAX PROFIT(Q) At USD 2.05 MM has Grown at 131.87%
  • NET PROFIT(Q) At USD 1.98 MM has Grown at 131.02%
  • DEBTORS TURNOVER RATIO(HY) Highest at 7.03 times
2

Risky - Negative EBITDA

3

High Institutional Holdings at 79.52%

4

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 204 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.79

stock-summary
Return on Equity

-17.84%

stock-summary
Price to Book

1.37

Revenue and Profits:
Net Sales:
13 Million
(Quarterly Results - Jun 2025)
Net Profit:
-13 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.47%
0%
20.47%
6 Months
0.45%
0%
0.45%
1 Year
151.89%
0%
151.89%
2 Years
-13.64%
0%
-13.64%
3 Years
-35.87%
0%
-35.87%
4 Years
-71.3%
0%
-71.3%
5 Years
0%
0%
0.0%

908 Devices, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
908 Devices, Inc. Hits New 52-Week High of $9.19, Reflecting Strong Growth

908 Devices, Inc. Hits New 52-Week High of $9.19, Reflecting Strong Growth

908 Devices, Inc. has achieved a new 52-week high of USD 9.19, reflecting a significant performance improvement from its previous low of USD 1.81. With a market capitalization of USD 204 million, the company operates in the pharmaceuticals and biotechnology sector, focusing on growth despite current losses.

Read More
908 Devices, Inc. Hits New 52-Week High of $9.00

908 Devices, Inc. Hits New 52-Week High of $9.00

908 Devices, Inc. has achieved a new 52-week high of USD 9.00, significantly up from its low of USD 1.81, reflecting a strong performance with a 44.77% gain over the past year. The company, with a market cap of USD 204 million, remains loss-making but resilient in the competitive pharmaceuticals sector.

Read More
908 Devices, Inc. Hits New 52-Week High at $8.79

908 Devices, Inc. Hits New 52-Week High at $8.79

908 Devices, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has achieved a new 52-week high of USD 8.79, reflecting a 41.06% increase from its low of USD 1.81. With a market cap of USD 204 million, the company shows resilience despite being loss-making.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.55%
EBIT Growth (5y)
-233.06%
EBIT to Interest (avg)
-28.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0.35
Tax Ratio
0.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
79.52%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.56
EV to EBIT
-4.25
EV to EBITDA
-5.08
EV to Capital Employed
3.48
EV to Sales
2.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-81.87%
ROE (Latest)
-16.05%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 29 Schemes (33.82%)

Foreign Institutions

Held by 39 Foreign Institutions (4.45%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 10.17% vs -37.23% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -31.63% vs 49.48% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13.00",
          "val2": "11.80",
          "chgp": "10.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "-7.10",
          "chgp": "109.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.90",
          "val2": "-2.60",
          "chgp": "-473.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-12.90",
          "val2": "-9.80",
          "chgp": "-31.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-20.60%",
          "val2": "-715.50%",
          "chgp": "69.49%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.73% vs 7.04% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -98.35% vs -8.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.60",
          "val2": "50.20",
          "chgp": "18.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-28.40",
          "val2": "-40.00",
          "chgp": "29.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-43.70",
          "val2": "-0.40",
          "chgp": "-10,825.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-72.20",
          "val2": "-36.40",
          "chgp": "-98.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-554.50%",
          "val2": "-844.20%",
          "chgp": "28.97%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
13.00
11.80
10.17%
Operating Profit (PBDIT) excl Other Income
0.70
-7.10
109.86%
Interest
0.00
0.00
Exceptional Items
-14.90
-2.60
-473.08%
Consolidate Net Profit
-12.90
-9.80
-31.63%
Operating Profit Margin (Excl OI)
-20.60%
-715.50%
69.49%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 10.17% vs -37.23% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -31.63% vs 49.48% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
59.60
50.20
18.73%
Operating Profit (PBDIT) excl Other Income
-28.40
-40.00
29.00%
Interest
0.00
0.20
-100.00%
Exceptional Items
-43.70
-0.40
-10,825.00%
Consolidate Net Profit
-72.20
-36.40
-98.35%
Operating Profit Margin (Excl OI)
-554.50%
-844.20%
28.97%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 18.73% vs 7.04% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -98.35% vs -8.33% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About 908 Devices, Inc. stock-summary
stock-summary
908 Devices, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."